Skip directly to content



Within InnoPlanT.NET, innovative developers and suppliers of medical products collaborate to enhance implants, transplants and bone graft substitutes. The aim is to enable faster and better integration and material life and functionality that is easier to control. To support this, new methods for production process monitoring and proof of longer life and functionality of the implants and transplants and products will be developed to improve the wound healing process following the transfer.


  • Interdisciplinary collaboration of professionals from the medical technology, biotechnology

Bio-Gate AG

Bio-Gate AG specialises in antimicrobial solutions for medical, consumer and industrial products and testing of the antimicrobial efficacy.

In addition Bio-Gate AG offers extensive support for application engineering. Products include the HyProtect™ technology, an antimicrobial silver-containing plasma coating for implants. This plasma coating features a very thin strong layer with long-lasting antimicrobial efficacy.


The ZIM cooperation network INNOPLANT.NET combines innovative medical product developers and suppliers in the fields of implants, transplants and bone substitution materials with the goal of further improving it by means of common research and development activities. Essentially, network partners define this as quicker and improved integration and easy-to-control longevity and functionality upon implantation or transplantation.

Network objectives are:

  • interdisciplinary collaboration of professionals from the medical technology, biotechnology and pharmaceuticals fields and highly-specialised


Under the control of a stringent quality assurance system, company specialists collaborate with scientists from the medical and technological fields to provide a steady flow of new products that are created in their own labs and manufacturing sites - from the initial idea to the completed implant. Real innovation combined with excellent product quality and efficient application take top priority. Core competencies: Modular hip and knee revision endoprothetics, primary hip and knee endrophrothetics, pedicle screw systems and spacers for spinal surgery, patient-specific implants.


Übernahme erfolgreich abgeschlossen

on 17. July 2013 - 17:59

RTI Biologics verkündet offiziell den Abschluss der erfolgreichen Übernahme von Pioneer® Surgical Technology. Mitte Juni bereits hatte RTI Biologics angekündigt, das Unternehmen für $ 130 Mio. erwerben zu wollen. Nun ist der Kauf vollzogen.

Pioneer Surgical ist ein 1992 im US-amerikanischen Marquette, Michigan gegründetes Unternehmen mit mittlerweile annähernd 300 Mitarbeitern weltweit. Es gilt als eines der führenden Unternehmen in der Herstellung und im Vertrieb von Metallimplantaten und synthetischen Materialien für den Einsatz in zahlreichen chirurgischen Bereichen, u.a.